ArticleNeurosurgical review2026
Analysis of influencing factors in patients with hypertensive intracerebral hemorrhage in the basal ganglia region treated with stereotactic surgery.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To explore the influencing factors of prognosis in patients with hypertensive intracerebral hemorrhage (HICH) in the basal ganglia region treated with stereotactic surgery. The clinical data of 116 cases with HICH who received stereotactic surgery from July 2022 to December 2024 were analyzed retrospectively. The outcome was evaluated using the modified Rankin Scale (mRS) and was dichotomized into favorable group (mRS 0 to 2) and unfavorable group (mRS 3 to 6) according to the follow-up results. The potential factors for unfavorable outcome were evaluated by univariate analysis and multivariate logistic regression analysis. Among the 116 patients, 52 (44.8%) patients had a favorable outcome, 64 (55.2%) patients had an unfavorable outcome. Univariate analysis showed that age, hemorrhage location, volume of hematoma, rupture into the ventricle, external ventricular drainage (EVD), preoperative Glasgow Coma Scale (GCS), postoperative residual hematoma or rebleeding, postoperative pneumonia were significantly correlated with the prognosis ( all P < 0.05). Multivariate logistic regression analysis suggested that age (OR = 1.105, 95%CI:1.049-1.164, P < 0.001), hemorrhage location (OR = 19.535, 95%CI:1.568-243.348, P = 0.021), volume of hematoma (OR = 1.095, 95%CI:1.040-1.153, P = 0.001) and postoperative residual hematoma or rebleeding (OR = 3.606, 95%CI:1.174-11.070, P = 0.025) might be factors affecting the prognosis in patients with HICH in the basal ganglia region treated with stereotactic surgery. The prognosis of patients with HICH in the basal ganglia region treated with stereotactic surgery is affected by multiple factors; age, hemorrhage location, volume of hematoma, residual hematoma or rebleeding after surgery are potential prognostic factors for outcomes.
Indexed as
Identifiers
42768231What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.